抗合成酶综合征( ASS)是一组以抗氨酰tRNA合成酶抗体阳性为特征的炎性肌病临床亚型,2010年才正式提出了ASS的诊断标准.根据抗合成酶抗体类型的不同分为不同的亚型,现已发现10 种抗合成酶抗体,包括抗组氨酰转运 RNA 合成酶(Jo-1)抗体、抗甘氨酰-tRNA合成酶(EJ)抗体、抗亮氨酰-tRNA合成酶(OJ)抗体、抗苏氨酰-tRNA合成酶(PL-7)抗体、抗丙氨酰-tRNA合成酶( PL-12 )抗体、抗门冬氨酰-tRNA合成酶( KS )抗体、抗苯丙氨酰-tRNA合成酶( Zo)抗体、抗谷氨酰-tRNA合成酶( JS)抗体、抗赖氨酰-tRNA合成酶( SC)抗体和抗酪氨酰-tRNA合成酶( YRS)抗体.不同亚型在临床表现、影像学表现、预后方面有所不同.本研究回顾性分析我院5例3种不同临床亚型ASS患者的临床资料,以期提高临床医师对本病的认识.
目的 探讨早期使用托伐普坦治疗老年急性心力衰竭(AHF)合并慢性肾功能不全(CKD)患者的有效性和安全性.方法 回顾性分析2016年7月至2021年7月住空军特色医学中心(原空军总医院)的102例AHF合并CKD的老年患者资料,并且在住院期间使用托伐普坦超过2 d.按照使用托伐普坦时间的早晚分为入院6 h内使用托伐普坦组(治疗组)与入院48 h后使用托伐普坦组(对照组).主要观察终点是2组患者住院期间肾功能恶化发生率、全因死亡率及住院时间.结果 与对照组比较,入院6h内使用托伐普坦组患者肾功能恶化发生率更低(4.08%比26.42%,χ2=9.602,P=0.002);全因死亡率更低(8.16%比22.64%,χ2=4.035,P=0.045).2组患者住院时长或使用托伐普坦剂量差异无统计学意义.结论 早期使用托伐普坦治疗AHF合并CKD患者是有效的,能显著减少患者肾功能恶化发生率,降低全因死亡率.
目的 探讨计算机断层扫描冠状动脉造影(CTCA)测量的血管狭窄程度和冠状动脉钙化评分(CACS),是否能预测接受非心脏手术患者的术后心血管事件.?方法 2013年6月至2018年6月在空军特色医学中心共有117例患者进行非心脏手术前接受CTCA.用CTCA测量血管狭窄程度和CACS,并根据修订的心脏风险指数(RCRI)评价临床危险因素.根据0,1,2或≥3个临床危险因素将患者分为0,1,2或≥3分RCRI组别.血管狭窄程度和CACS评分预测术后心血管事件.?结果 18例患者发生术后30 d心血管事件.有术后心血管事件的患者中肾功能不全、心力衰竭、心肌梗死比无事件患者统计值更高(χ2=9.517、6.978、4.148,P<0.05).与术后心血管事件发生相关的变量是≥3分RCRI[OR(95%CI)=10.941(2.732~28.153),P<0.01]和多支血管狭窄,其中2支血管狭窄[OR(95%CI)=11.278(3.119~38.254),P<0.01];3支或以上血管狭窄[OR(95%CI)=13.438(4.018~44.978),P<0.01].在用于预测心脏事件的CACS的受试者工作曲线(ROC)分析中,高CACS(113分以上)发生术后心血管事件显著增高[OR(95%CI)=6.842(2.882~18.204),P<0.01].?结论 在接受非心脏手术患者的术前危险分层中,CTCA评估进一步提高了RCRI评估的精确度.
代谢综合征(MS)已逐渐成为军事飞行人员的高发疾病.该文针对我国军事飞行人员MS中肥胖和高三酰甘油血症高发的特点,以2017年国际内分泌专家组提出的MS防治专家共识为基础,从饮食及生活方式干预的角度,梳理了近年来MS的防治措施及其循证医学证据,可为军事飞行人员MS的防治提供参考.
目的 探讨血栓通注射液联合替罗非班对急性脑梗死机械取栓患者预后的影响.方法 选取空军特色医学中心2019年1月-2020年6月收治的急性脑梗死患者180例,根据乱数表法将患者分为研究组和对照组各90例.对照组在机械取栓时经动脉鞘管注射盐酸替罗非班氯化钠注射液8 μg/kg,之后再以0.1 μg/(kg·min)的速率持续静脉泵入24 h,术后给予常规西药干预;研究组在对照组的基础上给予注射用血栓通静脉滴注14 d.比较2组患者的血管再通率、美国国立卫生研究院卒中量表评分(NIHSS)、改良Rankin评分(mRS)及血清神经营养因子(NTF)、神经生长因子(NGF)、神经元特异性烯醇化酶(NSE)水平和中医症状积分.结果 研究组的血管再通率为92.22%(83/90),高于对照组的82.22%(76/90)(P<0.05);研究组术后14 d的NIHSS评分、血清NSE水平和口舌歪斜、半身不遂、言语蹇涩评分及术后6个月的mRS评分均明显低于对照组(P<0.05),术后14d的血清NTF、NGF水平均明显高于对照组(P<0.05).结论 急性脑梗死机械取栓患者同时联合替罗非班及血栓通注射液治疗血管再通率更高,症状减轻更明显,神经功能恢复更好,有助于改善预后.
目的 评估老年营养风险指数是否有助于预测老年急性失代偿性心力衰竭(ADHF)住院患者的长期预后.方法 回顾性研究2013年6月至2018年6月在我院连续入院的年龄在65岁以上老年ADHF患者的病历资料.评估老年营养风险指数(GNRI),GNRI<92分被定义为营养不良.主要观察终点是比较低GNRI(<92分)组和高GNRI(≥92分)组2年内全因死亡.结果 47.67%的患者GNRI<92分,与GNRI≥92组比较,GNRI<92组体质指数(BMI)显著降低[(24.22±4.68)kg/m2比(18.53±2.52)kg/m2,P<0.01];B型钠尿肽、C反应蛋白、血红蛋白显著降低(P<0.01);Kaplan-Meier生存分析显示,GNRI<92组患者全因死亡率显著高于GNRI≥92组(HR=2.667,95%CI:1.527~4.651,P<0.001).多因素Cox比例风险回归分析显示:低GNRI(HR=0.947;95%CI:0.920~0.975,P<0.001)和年龄(HR=1.064;95%CI:1.026~1.012,P<0.001),是全因死亡率的强独立预测因子.结论 出院时应用GNRI进行营养评估有助于预测老年ADHF患者的长期预后.
目的 探讨托伐普坦在长寿老人(≥90岁)射血分数保留心衰(HFpEF)患者中应用的疗效及安全性.方法 采用自身对照的方法,回顾性选取2017年1月~2018年12月解放军空军特色医学中心收治的12例90岁以上HFpEF患者,对比分析加用托伐普坦前后心衰症状、不良反应、以及用药后2周、1月时尿量、血钠、肝肾功能、心功能等指标的变化.结果 1例因过敏反应停药.所有患者体液潴留的症状明显改善,用药后2周及1月时尿量均较用药前显著增加,差异有统计学意义(P<0.05);血清钠轻度升高,差异具有统计学意义(P<0.05);其他肝肾功能、心功能指标用药前后无显著改变.2例患者在此期间死于肺部感染.结论 托伐普坦对90岁以上HFpEF患者具有良好的疗效及安全性.
军队保健工作是一项特殊的医疗服务工作,保健医师需要谙熟健康管理学、保健医学、预防医学、老年医学、全科医学、营养学、心理学等多学科的理论知识和技能[1].目前国内的保健医学尚未形成独立、完整的学科体系,从业人员多由全科医师、老年病科医师或其他专科医师经过培训后担任.我院全军老年医学研究所,从事军队高级干部医疗保健服务工作数十年来,积累了丰富的工作经验,并参考有关全科医师的培训方法和模式[2],培养了保健专业的各级医师.现将我们多年来临床带教各级医师的经验及教学培训规划总结如下,可供保健、全科及老年病科等相关学科探讨和借鉴.
目的 探讨老年常见心血管疾病的临床特点以及治疗方法和预防措施.方法 回顾性分析180例老年常见心血管病患者的临床资料,分析病种、特点和伴随的疾病,总结临床疗效.结果 180例患者经过治疗后,显效175例(97.2%),有效4例(2.2%),无效1例(0.6%);高血压患者血压控制在140/90 mmHg水平,合并有糖尿病患者空腹血糖控制在(7.30±2.15) mmol/L.结论 老年常见心血管疾病有其独特的临床特点,早预防、早发现和针对性治疗对降低病死率,提高生活质量具有重要的作用.
Objective To provide reference and theoretical basis for the medical care in retired military cadres by analyzing the physical examination results of 3247 cases.Methods A total of 3247 cadres retired from army who took physical examination in our hospital from March 2014 to March 2016 were enrolled in this study .They were 2684 males and 563 females, and at an age of 75.0 ±13.8 (50-95) years.According to their age , they were divided into 50-59, 60-69, 70-79 and 80 -95 years groups (n=374, 1184, 1547 and 142).The results of physical examination , medical examination and laboratory test were collected and analyzed.Results Compared with other aged group , the 80-95 years group had higher ratios of females , more comorbidities of coronary heart disease, diabetes and hyperuricemia, higher proportion of medication, and lower 25-(OH)D3 level (P<0.05).Abdominal ultrasound results showed that fatty liver , hepatic cyst , gallbladder polyps , gallbladder stones and kidney stones were more common in the 80-95 years old group (P<0.05).Chest X-ray filming indicated there were more images of increased pulmonary markings , thoracic vertebra degeneration , obsolete pulmonary tuberculosis , pulmonary interstitial changes , arteriosclerosis , pulmonary emphysema , pulmonary patchy shadow and adhesion of the pleural cavity in the 80-95 years old group (P<0.05).Electrocardiogram indicated there were more images of ischemic change , bundle branch block ,sinus arrhythmia ,myocardial infarction ,left ventricular hypertrophy , premature contraction, atrial ventricular block in the 80 -95 years group ( P <0.05).At the same time, the incidence rates of mammary hyperplasia and uterine fibroids were higher in the females from the 60-69 years group , and those of prostate hypertrophy , prostatic calculus and prostatic calcification were common in the males of the 80 -95 years group ( P<0.05 ) .Conclusion The abnormality rates of medical examination results are quite high in the retired cadres .So, pertinent health guidance should be carried out and related risk factors should be monitored and controlled for the senile patients , so as to get benefits from early discovery and active intervention.More attention should be paid to the health care in those aged 80-95 years.
目的:研究血尿酸( SUA)水平与动脉粥样硬化( AS)评估指标及其危险因素的相关性。方法选取该院健康体检中心体检者577人,采用自动生化分析仪测定各项生化指标,超声检测颈动脉内中膜厚度( CIMT)。结果①与正常 UA 组比较,高 UA 组舒张压( DBP)、体重指数(BMI)、甘油三酯(TG)、颈动脉内膜厚度均增高,年龄、高密度脂蛋白(HDL)水平降低(P<0.001);②SUA 与收缩压(SBP)、DBP、BMI、空腹血糖(FPG)、TG、总胆固醇(TC)、载脂蛋白B、肌酐、尿素氮、血浆同型半胱氨酸、C反应蛋白(CRP)呈正相关,与载脂蛋白A、HDL呈负相关;以 CIMT为因变量,CIMT的独立相关因素是年龄(β=0.01,P<0.05)、血UA(β=3.74,P=0.001);③与男性组相比,女性组除年龄、HDL、载脂蛋白 A高于男性组,余均低于男性组(P<0.05)。结论在体检人群中,血UA与AS评估指标及其危险因素有明显的相关性,是AS早期危险因素预测因子之一,其与常见危险因素有叠加暴露相关性,从降低血UA水平入手预防AS可能是重要路径之一。
Objective To investigate the clinical significance of brachial-ankle pulse wave velocity(baP-WV)in healthy people who were classified by blood pressure and age.Methods A total of 1750 healthy subjects without cerebral-cardiovascular diseases in the physical examination were recruited.The data of baPWV,blood pres-sure,glucose,lipid,body mass index,smoking,alcohol drinking and drugs were collected.Results After adjusting for age and blood pressure,the diabetes,drugs for anti-hypertensive drugs and lipid-lowering drugs were related with baP-WV,and the rest 1237 persons without these factors were selected as control group.Conclusion The study provides the reference value of baPWV in healthy people classified by blood pressure and age,which may be valuable for the selection of baPWV test for people in different states of ages and blood pressure in health examination,and the preven-tion of arterial stiffness.
Objective To explore the effect of vascular age calculated by Chinese carotid intima-media thick-ness (CIMT)reference on the risk assessment of cardiovascular disease.Methods 1522 health examinees (more than 30 years old)without cardiovascular diseases were selected.The vascular age was calculated by "median value"of CIMT.The risk assessment of ischemic cardiovascular diseases were calculated by vascular age and chronological age, respectively Results The vascular age was larger than chronological age by 9.5 years (P <0.01),and the difference between vascular age and chronological age was more than 5 years among 77% of the health examinees.There were significant differences in the risk scores of ischemic cardiovascular diseases between vascular age and chronological age among two thirds of the health examinees (P <0.01).The risk of cardiovascular diseases in almost 10 % of the health examinees was when chronological age was substituted by vascular age (P <0.01).Conclusion Chronologi-cal age is different from CIMT-derived vascular age ,which could increased the risk of cardiovascular diseases.
目的:观察老年2型糖尿病患者估测肾小球滤过率( GFR)与臂踝脉搏波速度( baPWV)的相关性。方法入选156例老年2型糖尿病患者,以简化MDRD公式估算肾小球滤过率(GRF),根据 eGFR 值将研究对象分为两组:A 组 eGFR>90 ml· min-1·1.73 m-2,B 组 eGFR 60~90 ml· min-1·1.73 m-2。比较两组间baPWV 的差异,运用 Pearson相关分析及多元线性回归分析 baPWV与 eGFR及年龄、收缩压、糖化血红蛋白(HbA1c)、尿微量白蛋白及糖尿病病程等因素的相关性。结果 B组baPWV明显高于A组(P<0.001); Pearson相关分析显示baPWV与eGFR呈负相关(r=-0.532,P<0.001),偏相关分析显示控制年龄、收缩压、HbA1c、尿微量白蛋白及糖尿病病程等因素后,baPWV与 eGFR仍呈显著负相关(r=-0.253,P=0.002)。多元逐步回归分析显示baPWV与年龄、收缩压及eGFR独立相关。结论老年2型糖尿病患者早期肾功能损害可能导致动脉硬化的发生和发展。
<正>1病历摘要我科于今年6月25日收治1名92岁男性患者,因"发现皮肤出血点3 d"入院。患者入院前3 d发现舌尖出现小血泡,右前臂出现3个米粒大小的出血点,局部皮肤无疼痛、瘙痒,未在意。入院当日发现右臂出现散在针尖样出血点,为进一步诊治来院。患者既往患高血压、冠心病、肺栓塞、高脂血症、陈旧
Objective To analyze the medication with β blocker in elderly patients with stable angina.Methods From June 1,2010 to December 1,2010,investigations were made among the patients with coronary heart diseases in our hospital.Among them,186 elderly patients with stable angina were selected out and their clinical data were statistically analyzed.Results The usage rate of β blocker was 54.8%(102/186) among these patients.There was no significant difference in the usage rate(P>0.05) among ones with different gender and age.Conclusion The usage rate of β blocker is low among senile patients with stable angina and the dosage is insufficient,which indicates the insufficient usage of this kind of medicine.
目的探讨老年期谵妄发生原因及防治措施。方法对我院8例老年期谵妄患者临床资料进行回顾性分析。结果谵妄并非精神科所特有,在临床各科,谵妄往往与脑器质性疾病、躯体性疾病并存,常见病因有脑梗死、肺部感染、术后、电解质紊乱等。结论加强精神卫生知识学习及学科间渗透,能及时识别谵妄,提高诊断率,改善患者预后。
目的 了解老年慢性稳定性心绞痛药物应用现状及危险因素控制情况.方法 于2010年6月1日至2010年12月1日期间对空军总医院门诊部冠心病患者进行调查,筛选资料完整的186例慢性稳定性心绞痛患者,对收集的数据进行统计分析.结果 调查中资料完整的186例老年慢性稳定性心绞痛患者中抗血小板药物、硝酸酯类、他汀类药物、β受体阻滞剂、血管紧张素转换酶抑制剂/血管紧张素受体拮抗剂、钙离子拮抗剂药物使用率分别为87.1%(162/186)、84.9%( 158/186)、68.8%( 128/186)、54.8%( 102/186)、50.0%( 93/186)、48.4%( 90/186),不同性别组间差异无统计学意义(P>0.05).患者低密度脂蛋白胆固醇控制达标率34.9%( 65/186),合并高血压或慢性肾病者血压控制达标率58.3%(77/132),合并糖尿病或糖耐量异常者糖化血红蛋白(HbA1c)控制达标率43.1%( 25/58),血脂、血压及血糖达标率在不同性别组间差异无统计学意义(P>0.05).结论 老年慢性稳定性心绞痛患者中各药物应用情况较指南要求尚有明显差距,各危险因素控制达标率仍亟待提高.
This is to discuss Amifostine mechanism by analyzing one case with Idiopathic Thrombocytopenic Purpura(ITP).ITP is not difficult to diagnozed.Many drugs are used to treat it.One 92-year-old male patient with ITP was not ameliorated by routine treatment.Finally he was cured by Amifostine.Then he was followed-up for 5 months without recurrence.We can say that Amifostine is safe and effective,further more it is possible a potentional medicine to cure elderly serious ITP.
目的观察老年高血压患者动态动脉硬化指数(AASI)与颈动脉粥样硬化及微量白蛋白尿(MAU)的相关性及AASI在老年高血压患者心血管风险评估中的作用。方法 172例行24 h动态血压监测的住院老年高血压患者,根据文献方法计算AASI,以AASI<0.55或AASI≥0.55分为两组,比较各组颈动脉内中膜厚度(IMT)、颈动脉斑块指数及MAU的差异,以及与AASI的相关性。结果两组比较,在AASI≥0.55组中,其IMT、颈动脉斑块指数及MAU水平显著高于AASI<0.55组(P<0.001);Pearson相关分析显示,AASI与IMT、颈动脉斑块指数及MAU呈显著正相关,其相关系数分别为:IMT(r=0.560,P<0.001)、颈动脉斑块指数(r=0.591,P<0.001)、MAU(r=0.538,P<0.001);控制年龄、平均收缩压、平均舒张压、血肌酐水平、eGFR等因素后,偏相关分析显示,AASI仍与IMT、颈动脉斑块指数及MAU显著相关;多元逐步回归分析显示IMT、颈动脉斑块指数及MAU均与AASI独立相关,其标准化偏回归系数分别为:0.260、0.252、0.337,P<0.001。结论在老年高血压患者,AASI与IMT、颈动脉斑块指数及MAU水平呈显著正相关,AASI可作为老年高血压患者心脑血管事件风险的独立预测因素。